AxoGen Announces U.S. Market Launch Of AxoGuard™ Nerve Protector And AxoGuard™ Nerve Connector To Treat Peripheral Nerves

Main Category: Neurology / Neuroscience
Article Date: 07 Sep 2009 - 3:00 PDT

email to a friend   printer friendly   opinions  

AxoGen, Inc. announced the U.S. market launch of AxoGuard™ Nerve Protector and AxoGuard™ Nerve Connector for the treatment of peripheral nerve injuries. The launch was announced at the American Society for Surgery of the Hand in San Francisco.

AxoGuard™ Nerve Protector is designed to wrap and protect peripheral nerves. It can reinforce a coaptation site, wrap a partially severed or compressed nerve, and isolate nerve tissue during the healing process. The design minimizes the potential for scar formation and nerve entrapment while reducing the risk of neuromas. It allows the nerve to glide within a protective covering while gradually remodeling into the patient's own tissue.

AxoGuard™ Nerve Connector is designed to align and connect peripheral nerves. It is a coaptation aid, meaning it joins together two nerve endings, allowing close approximation and alignment of severed nerve ends.

"We are very pleased to add AxoGuard™ Nerve Protector and AxoGuard™ Nerve Connector to our portfolio of peripheral nerve repair products," said Jamie Grooms, CEO and Co-founder of AxoGen. "With these products and our national sales and marketing support network, AxoGen is more than ever a resource and partner with surgeons working to treat the peripheral nerve injuries that affect thousands of patients each year."

AxoGuard™ Nerve Protector and AxoGuard™ Nerve Connector are comprised of a three-dimensional extracellular matrix that supports regeneration and healing. AxoGuard™ works with the body to remodel and revascularize, allowing the products to support the natural nerve healing process. In addition, AxoGuard™, unlike other materials such as synthetics, is able to be implanted into a contaminated or dirty wound, since the material is resistant to infection.

AxoGuard™ is available nationally and will be sold through the AxoGen sales network. AxoGen also distributes Avance®, the first decellularized and cleansed, sterile three-dimensional scaffold from donated human peripheral nerve. Avance® is designed to bridge peripheral nerve gaps. It structurally supports the patient's own regeneration process to repair the nerve.

Source
AxoGen

• Additional
• References
• Citations